Log in to save to my catalogue

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatm...

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519899

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments

About this item

Full title

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments

Publisher

Singapore: Springer Singapore

Journal title

Journal of gastroenterology, 2020-10, Vol.55 (10), p.927-943

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Changes in body composition are associated with poor outcomes in cancer patients including hepatocellular carcinoma (HCC). Sarcopenia, defined as the loss of skeletal muscle mass, quality and function, has been associated with a higher rate of complications and recurrences in patients with cirrhosis and HCC. The assessment of patient general status...

Alternative Titles

Full title

Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519899

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519899

Other Identifiers

ISSN

0944-1174,1435-5922

E-ISSN

1435-5922

DOI

10.1007/s00535-020-01711-w

How to access this item